Co-administration of an ETA receptor antagonist with sFlt-1 completely abolished hypertension (Table 1), strongly supporting ET-1 as an important mediator of sFlt-1 induced hypertension [8]. The gene discussed is EDN1; the disease is hypertensive disorder.